Polaris Management Co. VII, L.L.C. → Camp4 Therapeutics Corporation CAMP

Stake: 6.30% Shares: 3,023,161 CUSIP: 13463J101 Class: Common Stock, par value $0.0001 per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

1 transaction

1 buys · 0 sales · 0 awards/exercises

Issuer Cluster

4 13D/G filings on this issuer

3 other filings besides this one

Filer Track Record

2 filings by this filer

1 other filing in the data moat

Short Interest · settle 2026-09-30

DTC 5.13

1,459,951 shares short · +47.1% vs prior

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-08-31	Gold Kelly	officer	Buy	10,000	$3.96	$40K

Other 13D/G Filings on Camp4 Therapeutics Corporation

Filed	Form	Filer	Stake	Shares
2026-08-31	SCHEDULE 13D/A	5AM Ventures VI, L.P.	9.90%	2,033,270	view →
2026-08-05	SCHEDULE 13D/A	5AM Ventures VI, L.P.	9.90%	2,625,145	view →
2025-09-15	SCHEDULE	Enavate Sciences GP, LLC	8.10%	3,785,802	view →

Other Filings by Polaris Management Co. VII, L.L.C.

Filed	Form	Issuer	Stake	Shares
2022-02-11	SC	SQZ Biotechnologies Co	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →